Cargando…

Cyclophosphamide in systemic sclerosis: still in search of a 'real life' scenario

In systemic sclerosis (SSc), there is no proven treatment to prevent disease progression. In a recent meta-analysis of three randomised controlled trials (RCTs) and six open prospective studies on cyclophosphamide (CYC), no significant changes in lung function were observed. However, CYC is associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miniati, Irene, Valentini, Gabriele, Cerinic, Marco Matucci
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688227/ https://www.ncbi.nlm.nih.gov/pubmed/19226435 http://dx.doi.org/10.1186/ar2576

Ejemplares similares

Treatment of systemic sclerosis: is there any hope for the future?
por: Allanore, Yannick, et al.
Publicado: (2016)

The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?
por: Manetti, Mirko, et al.
Publicado: (2016)

Interstitial pneumonia with autoimmune features: a new classification still on the move
por: Cavagna, Lorenzo, et al.
Publicado: (2018)

Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?
por: Vonk, Madelon C
Publicado: (2020)

Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide
por: Borghini, Annalisa, et al.
Publicado: (2015)

Registry Evaluation of Digital Ulcers in Systemic Sclerosis
por: Galluccio, Felice, et al.
Publicado: (2010)

Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide
por: Villano, Marilisa, et al.
Publicado: (2013)

Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review
por: Fioretto, Bianca Saveria, et al.
Publicado: (2023)

Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis
por: Romano, Eloisa, et al.
Publicado: (2022)

The Contribution of Imaging Beyond Clinical Diagnosis, the Ochronosis and Synovio-entheseal Complex Examples
por: Pacini, Giovanni, et al.
Publicado: (2022)

Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis
por: Rosa, Irene, et al.
Publicado: (2021)

Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data
por: Fiorentini, Elisa, et al.
Publicado: (2022)

New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy
por: Romano, Eloisa, et al.
Publicado: (2021)

Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment
por: Romano, Eloisa, et al.
Publicado: (2022)

A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis
por: Manetti, Mirko, et al.
Publicado: (2014)

Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis
por: Manetti, Mirko, et al.
Publicado: (2010)

The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress
por: Orlandi, Martina, et al.
Publicado: (2020)

Clinical trials in systemic sclerosis: lessons learned and outcomes
por: Matucci-Cerinic, Marco, et al.
Publicado: (2007)

Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis
por: Manetti, Mirko, et al.
Publicado: (2022)

Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets
por: Nevskaya, Tatiana, et al.
Publicado: (2021)

Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma
por: Matucci-Cerinic, Marco, et al.
Publicado: (2021)

One year later: The case of tocilizumab in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2022)

Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis
por: Manetti, Mirko, et al.
Publicado: (2013)

The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview
por: Fioretto, Bianca Saveria, et al.
Publicado: (2020)

COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic
por: Denton, Christopher P, et al.
Publicado: (2020)

The Treatment of Lung Involvement in Systemic Sclerosis
por: Ruaro, Barbara, et al.
Publicado: (2021)

Still in search of a herbal medicine…
por: Thatte, Urmila
Publicado: (2009)

Interstitial lung disease in systemic sclerosis: where do we stand?
por: Cappelli, Susanna, et al.
Publicado: (2015)

Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement
por: De Luca, Giacomo, et al.
Publicado: (2021)

Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis
por: Rosa, Irene, et al.
Publicado: (2023)

Systemic Sclerosis Association with Malignancy
por: Lepri, Gemma, et al.
Publicado: (2022)

Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound
por: Karalilova, Rositsa Valerieva, et al.
Publicado: (2021)

Photographer's guide to the digital lifecycle: real-life workflow scenarios for managing still and motion photography assets
por: Greisler, Ben
Publicado: (2011)

Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life
por: El Aoufy, Khadija, et al.
Publicado: (2023)

In Systemic Sclerosis, Anxiety and Depression Assessed by Hospital Anxiety Depression Scale Are Independently Associated with Disability and Psychological Factors
por: Del Rosso, Angela, et al.
Publicado: (2013)

Systemic sclerosis in the time of COVID-19
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2022)

Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study
por: Campochiaro, Corrado, et al.
Publicado: (2023)

Rehabilitation of the face and temporomandibular joint in systemic sclerosis
por: Maddali Bongi, Susanna, et al.
Publicado: (2021)

Cryptosporidium: Still Open Scenarios
por: Pane, Stefania, et al.
Publicado: (2022)

Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis
por: Manetti, Mirko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eofmtihenpob70en6bt0de6lrc